CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
Abstract
Authors
C Chouaid N Girard A Kron M Scheffler C Knott L Bosquet J Trigo S Viteri M Sebastian S Popat N Rahhali R Toueg B Rodrigues J Diels CA Schioppa J Cabrieto J Sermon NJ Perualila N Erdmann J Mielke M Nematian-Samani I Pfaira C Martin-Fernandez P Mahadevia T Li C Pick-Lauer A Adamczyk J Penton J Wolf